差價合約(CFD)是複雜的工具,由於槓桿作用,存在快速虧損的高風險。81.3% 的散戶投資者在與該提供商進行差價合約交易時賬戶虧損。 您應該考慮自己是否了解差價合約的原理,以及是否有承受資金損失的高風險的能力。

Equities

Noteworthy Belgian, French & Swiss Equities

Michael Brown
Senior Research Strategist
2024年1月15日
Pepperstone has begun to significantly widen the range of European equities listed for clients to trade. In this article, we look at some of the most notable Belgian, French, and Swiss stocks that are now available.

Belgium

We start with Belgium, where a handful of notable names standout.

Perhaps the most well-known is Anheuser-Busch InBev (more commonly known as AB InBev), the world’s largest brewer, with over 600 brands being sold worldwide, including names such as Budweiser, Corona, and Stella Artois. The group has its primary listing in Brussels, along with secondary listings in Mexico, Johannesburg and New York. While 2023 proved a rather torrid year for the firm, amid a significant advertising controversy, the final quarter of the year saw a substantial recovery in the stock’s price, which gained ground in line with the broader risk rally taking place at the time. Nevertheless, and despite being classed as a consumer staple, headwinds may intensify during the year ahead, particularly if economic momentum wanes as consensus expects.

Preview

Financials also feature heavily in the range of Belgian stocks being listed, including the nation’s second-largest bank (by assets) KBC Group, as well as a handful of notable holding companies such as GBL and Sofina, both of which have various interests across a range of sectors within Europe.

France

Turning to France, where the luxury goods sector features heavily, with names such as LVMH, Hermes, Dior and Kering all standing out.

The sector has struggled significant of late, with all the aforementioned firms still in the midst of a share price slump that started all the way back in Q2 23, driven largely by the continued sluggish performance of the Chinese economy, and the subsequent decline in overseas demand for luxury goods. Any relief for these rather beleaguered stocks is likely to hinge on a substantial pick-up in foreign demand, likely as a result of additional fiscal stimulus being delivered in the world’s second largest economy.

Preview

Elsewhere, numerous well-known banks including BNP Paribas, Credit Agricole, and Societe Generale feature among the newly listed equities. Earnings among eurozone banks should remain relatively solid over the next twelve months, though margins may be somewhat compressed as the ECB are likely to deliver a significant amount of deposit rate cuts over the course of 2024.

A handful of other, cyclical stocks also standout from the round of newly listed equities, including aerospace giant Airbus, whose share price has taken off as a result of the ongoing wave of aging fleet replacement across the global airline industry, as well as insurance giant Axa, and chemicals conglomerate Air Liquide, who are making increasing waves in the carbon capture space.

Preview

Switzerland

Finally, we turn to Switzerland, and an equity market that, perhaps, attracted more attention than it typically would in 2023, as a result of the well-documented collapse of Credit Suisse, and subsequent forced marriage with arch-rival UBS.

Shares in the country’s largest bank have enjoyed a strong run since the tumult of last March, rallying over 50% during said period, though the integration of their failed rival does pose an ongoing risk that the bank, and traders alike, will have to continue to manage.

Preview

Meanwhile, a handful of well-known healthcare names are now also available for Pepperstone clients to trade, including the world’s fourth- and fifth-largest pharma firms by revenue in Novartis and Roche respectively. Other notable stocks include Nestlé, the world’s largest publicly held food company, in addition to a host of insurance behemoths including Chubb, Zurich, Swiss Re, and Swiss Life.

這裡提供的資料並未根據旨在促進投資研究獨立性的法律要求進行準備,因此被視為市場營銷溝通。儘管它不受任何在投資研究傳播之前交易的禁制,我們不會在向客戶提供資料之前尋求任何優勢。

Pepperstone不代表這裡提供的材料是準確、及時或完整的,因此不應依賴於此。這些資訊,無論來自第三方與否,不應被視為建議;或者買賣的提議;或者購買或出售任何證券、金融產品或工具的招攬;或參與任何特定的交易策略。它不考慮讀者的財務狀況或投資目標。我們建議閱讀此內容的讀者尋求自己的建議。未經Pepperstone的批准,不允許複製或重新分發此信息。